Patent: 9,796,986
✉ Email this page to a colleague
Summary for Patent: 9,796,986
Title: | Serum-free stable transfection and production of recombinant human proteins in human cell lines |
Abstract: | The present invention relates to an improved method for the serum-free production of an immortalized human cell line stably transfected under serum-free conditions with a specific vector carrying the gene coding for the protein of interest. Furthermore the invention relates to a production cell line obtained by said method, a production method for said protein of interest utilizing said production cell line, and the specific vector carrying the gene of interest itself. |
Inventor(s): | Schroeder; Carola (Heidelberg, DE), Ding; Haiyan (Munich, DE), Wegmann; Cathleen (Munich, DE) |
Assignee: | OCTAPHARMA AG (Lachen, CH) |
Application Number: | 15/369,068 |
Patent Claims: | see list of patent claims |
Details for Patent 9,796,986
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2025-06-30 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2025-06-30 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2025-06-30 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |